In a mouse model of lung fibrosis, fibrosis was induced through intratracheally instilled bleomycin and mice were treated with the catalytic FAK inhibitor PF-562,271 or with siRNAs targeting FAK. The gene discussed is PTK2; the disease is pulmonary fibrosis.